The page is the record's research on the issuer — no analyst, no rating, no view. # BICYCLE THERAPEUTICS PLC (NASDAQ: BCYC) — research page As of 2026-11-08 · us-cm-kg · record version 1 ## Identity and listing The issuer is BICYCLE THERAPEUTICS PLC, listed on NASDAQ under ticker BCYC, with ISIN US0887861088. The LEI is not on the record (no GLEIF record with the exact legal name in jurisdiction US-X0). The security type is Corporate, the segment is not on the record, the sector is 2834 Pharmaceutical Preparations, and the jurisdiction is United Kingdom. The listing status is listed, not halted. ## The disclosure read The record holds 83 filings across 32 filing days in the window 2025-11-08 to 2026-11-08. The filings comprise 39 directors' dealings, 28 regulatory filings, 8 results, 3 AGM/EGM, 3 corporate news and 2 director changes. The median gap between filing days is 7 days. The latest filing is a results filing dated 2026-10-29, 10 days before the record date of 2026-11-08. On NASDAQ the median gap is 6.0 days, the median filings are 52 and the median latency is 5.0 days across 4,359 issuers. In the sector 2834 Pharmaceutical Preparations the median gap is 6.0 days, the median filings are 63.0 and the median latency is 4.0 days across 526 issuers. ## Auditor The auditor is not on the record (no dei:AuditorName tag on the latest annual report cover; foreign private issuers and older filings carry none). The auditor's location is not on the record. The record holds no auditor changes. ## Events and halts The record holds no listing, delisting or name change lines. The domicile change is not on the record (EDGAR states no dated change of state of incorporation on a filing line). The segment move is not on the record (the exchanges' tier transfers are not EDGAR filings). The halt flag is listed, not halted. ## Orderability The outcome is not determinable. The chapter's orderability section carries no client categories, so the outcome cannot name its client category. The rule version is acm-68000/us/reasonable-basis-suitability-finra-rule-2111/r1, and the chapter is as of 2026-11-04. ## Coverage No research houses were found on the issuer's own investor-relations page; the count is 0. ## Open research No openly published research notes were found; the count is 0. ## Licensed Licensed research: none loaded. A licensed row is served only to an agent whose firm holds that licence (licensor, entitlement). No licensed row is loaded. ## As-of depth The sealed years that hold the issuer are 2021, 2022, 2023, 2024, 2025 and 2026. The market's earliest sealed date is 2021-01-04. The live record began on 2026-09-12. ## Sources 7 source pages are named on this page; every value above carries its own source page and read date in the numbers. - https://www.sec.gov/files/company_tickers_exchange.json (identity.exchange) - https://www.sec.gov/data-research/sec-markets-data/fails-deliver-data (identity.isin) - https://data.sec.gov/submissions/CIK0001761612.json (identity.jurisdiction) - https://mcp.us-cm-kg.ai/events/NASDAQ/BCYC (the disclosure lines) - https://www.nasdaqtrader.com/rss.aspx?feed=tradehalts (the halt flag) - https://mcp.us-cm-kg.ai/book/aio.json (the orderability chapter) - https://mcp.us-cm-kg.ai/record/NASDAQ/BCYC (the record) --- Allooloo Technologies Corp. · https://getresearch.ai/us/NASDAQ/BCYC · public-record only · the same page signed and receipted: get_research at https://mcp.getresearch.ai/mcp